133 related articles for article (PubMed ID: 20500494)
1. The efficacy of imiquimod 5% cream (Aldara® in the treatment of aural plaque in horses: a pilot open-label clinical trial.
Torres SM; Malone ED; White SD; Koch SN; Watson JL
Vet Dermatol; 2010 Oct; 21(5):503-9. PubMed ID: 20500494
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod treatment for Equus caballus papillomavirus infection in equine aural plaques.
Zakia LS; Olivo G; Basso RM; Mira J; Herman M; Araujo JP; Borges AS; Oliveira-Filho JP
Vet Dermatol; 2016 Jun; 27(3):175-e44. PubMed ID: 27109291
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: a pilot study.
Nogueira SA; Torres SM; Malone ED; Diaz SF; Jessen C; Gilbert S
Vet Dermatol; 2006 Aug; 17(4):259-65. PubMed ID: 16827669
[TBL] [Abstract][Full Text] [Related]
4. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
Diamantis ML; Bartlett BL; Tyring SK
Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with equine aural plaque in Brazil.
Mira J; Herman M; Zakia LS; Olivo G; Araujo JP; Borges AS; Oliveira-Filho JP
Vet Dermatol; 2016 Oct; 27(5):408-e104. PubMed ID: 27417263
[TBL] [Abstract][Full Text] [Related]
6. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream.
Deeths MJ; Chapman JT; Dellavalle RP; Zeng C; Aeling JL
J Am Acad Dermatol; 2005 Feb; 52(2):275-80. PubMed ID: 15692473
[TBL] [Abstract][Full Text] [Related]
7. Auricular chondrosis in a horse.
Bowers JR; Slocombe RF
Aust Vet J; 2009 Jun; 87(6):219-21. PubMed ID: 19489778
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial.
Ooi T; Barnetson RS; Zhuang L; McKane S; Lee JH; Slade HB; Halliday GM
Br J Dermatol; 2006 Jan; 154(1):72-8. PubMed ID: 16403097
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals.
Harwood CA; Perrett CM; Brown VL; Leigh IM; McGregor JM; Proby CM
Br J Dermatol; 2005 Jan; 152(1):122-9. PubMed ID: 15656812
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot study.
Bernstein DI; Spruance SL; Arora SS; Schroeder JL; Meng TC
Clin Infect Dis; 2005 Sep; 41(6):808-14. PubMed ID: 16107978
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma.
Blasi MA; Giammaria D; Balestrazzi E
Am J Ophthalmol; 2005 Dec; 140(6):1136-9. PubMed ID: 16376667
[TBL] [Abstract][Full Text] [Related]
12. Apparent clinical resolution of pinnal actinic keratoses and squamous cell carcinoma in a cat using topical imiquimod 5% cream.
Peters-Kennedy J; Scott DW; Miller WH
J Feline Med Surg; 2008 Dec; 10(6):593-9. PubMed ID: 18417398
[TBL] [Abstract][Full Text] [Related]
13. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
Syed TA; Hadi SM; Qureshi ZA; Ali SM; Kwah MS
J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759
[TBL] [Abstract][Full Text] [Related]
14. An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women.
Garland SM; Waddell R; Mindel A; Denham IM; McCloskey JC
Int J STD AIDS; 2006 Jul; 17(7):448-52. PubMed ID: 16820073
[TBL] [Abstract][Full Text] [Related]
15. Fractional Laser-Assisted Topical Imiquimod 5% Cream Treatment for Recalcitrant Common Warts in Children: A Pilot Study.
Park SM; Kim GW; Mun JH; Song M; Kim HS; Kim BS; Kim MB; Ko HC
Dermatol Surg; 2016 Dec; 42(12):1340-1346. PubMed ID: 27598444
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day.
Gollnick H; Barasso R; Jappe U; Ward K; Eul A; Carey-Yard M; Milde K
Int J STD AIDS; 2001 Jan; 12(1):22-8. PubMed ID: 11177478
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients.
Célestin Schartz NE; Chevret S; Paz C; Kerob D; Verola O; Morel P; Lebbé C
J Am Acad Dermatol; 2008 Apr; 58(4):585-91. PubMed ID: 18068265
[TBL] [Abstract][Full Text] [Related]
18. Off-label indications for imiquimod.
Ganjian S; Ourian AJ; Shamtoub G; Wu JJ; Murase JE
Dermatol Online J; 2009 May; 15(5):4. PubMed ID: 19624982
[TBL] [Abstract][Full Text] [Related]
19. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
Sotiriou E; Apalla Z; Maliamani F; Zaparas N; Panagiotidou D; Ioannides D
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1061-5. PubMed ID: 19470041
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod in clinical practice.
Edwards L
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
